Laurie J. Olson - Jan 3, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Director
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Jan 3, 2023
Transactions value $
-$112,620
Form type
4
Date filed
1/5/2023, 03:39 PM
Previous filing
Oct 12, 2022
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $84.9K +1K $84.86 1K Jan 3, 2023 Direct
transaction KRTX Common Stock Sale -$197K -1K -100% $197.48 0 Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -1K -6.25% $0.00 15K Jan 3, 2023 Common Stock 1K $84.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2022.
F2 This option vests and becomes exercisable in thirty-six equal monthly installments beginning on August 12, 2020.